Description of Research Expertise:
Molecular genetics and pathology of Leukemias and Lymphomas; Myelodysplastic syndromes; Minimal residual disease; Hodgkin lymphoma
Baraban E, Sadigh S, Rosenbaum J, Van Arnam J, Bogusz AM, Mehr C, Bagg A.: Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease. Br J Haematol. : 2019.
Caponetti GC, Bagg A: Genetic studies in the evaluation of myeloproliferative neoplasms. Semin Hematol. : 2019.
Kluk MJ, Bagg A: Expedited analysis and reporting of multiple mutations that modify medical management in myeloid malignancies: It's about (turn-around) time! Journal of Molecular Diagnostics : 2019.
Salehi S, Astle JM, Sadigh S, Lake J, Aikawa V, Tang G, Wang SA, Bagg A.: Myeloid neoplasm with eosinophilia and PCM1-JAK2 associated with acute
promyelocytic leukemia with PML-RARA. Leuk Lymphoma. : 2019.
Sadigh S, Morrissette JJD, Bagg A.: FBXW7 mutations in acute myeloid leukemia. Leuk Lymphoma : 2019.
Wang J, Rea B, Haun P, Emerson R, Kirsch I, Bagg A.: High-Throughput Sequencing of the T-cell receptor beta chain gene distinguishes two subgroups of cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology : 2018.
Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, Wang SA, Bueso-Ramos CE, Orazi A, Arber DA, Hexner EO, Babushok DV, Bagg A.: Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2
V617F mutation: a multi-institutional study from the bone marrow pathology group. Modern Pathology : 2018.
Rea B, Haun P, Emerson R, Vignali M, Farooqi M, Samimi S, Elenitsas R, Kirsch I, Bagg A.: Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma. J Clin Pathol. : 2018.
Aynardi J, Manur R, Hess PR, Chekol S, Morrissette JJD, Babushok D, Hexner E, , Rogers HJ, Hsi ED, Margolskee E, Orazi A, Hasserjian R, Bagg A.: JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group. Br J Haematol. : 2018.
Kim MY, Yu KR, Kenderian SS, Ruella M, Chen S, Shin TH, Aljanahi AA, Schreeder D, Klichinsky M, Shestova O, Kozlowski MS, Cummins KD, Shan X, Shestov M, Bagg A, Morrissette JJD, Sekhri P, Lazzarotto CR, Calvo KR, Kuhns DB, Donahue RE, Behbehani GK, Tsai SQ, Dunbar CE, Gill S.: Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia. Cell : 2018.
160., Ohgami RS, Rosenwald A, Bagg A: Next-Generation Sequencing for Lymphomas:
Perfecting a Pipeline for Personalized Pathobiologic and Prognostic Predictions Journal of Molecular Diagnostics : 2019.